EGFR and non-small cell lung carcinoma: The results were similar to those obtained after treatment with cetuximab alone; however, radiolabeling of cetuximab with 47Sc was more effective in killing NSCLC cells by targeting the EGFR antigen and inducing DNA damage caused by β irradiation emitted from the conjugated 47Sc.